Glympse Bio.
Drug Discovery
Current Valuation
N/A
As of December 17, 2021
Total Funding Raised
N/A
Across 1 round
Last Round
Later Stage VC (Series B)
$18.0M
Last Funding
Dec 2021
Funding date
Capital Efficiency
N/A
Valuation / Funding
Interested in buying or selling Glympse Bio. shares?
Get a free quote from our secondary market team. We facilitate transactions from $250K to $500M+.
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| December 17, 2021 | Later Stage VC (Series B) | $18.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Glympse Bio. is currently valued at N/A as of December 17, 2021.
What is Glympse Bio. Worth in 2026?
Glympse Bio. is a leading private company in the Drug Discovery sector. Track Glympse Bio.'s valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Glympse Bio. Valuation is Determined
Private company valuations like Glympse Bio.'s are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.